Cargando…

An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy

The paralogous scaffold proteins axin and conductin/axin2 are key factors in the negative regulation of the Wnt pathway transcription factor β-catenin, thereby representing interesting targets for signaling regulation. Polymerization of axin proteins is essential for their activity in suppressing Wn...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernkopf, Dominic B., Brückner, Martina, Hadjihannas, Michel V., Behrens, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751202/
https://www.ncbi.nlm.nih.gov/pubmed/31534175
http://dx.doi.org/10.1038/s41467-019-12203-8
_version_ 1783452572226420736
author Bernkopf, Dominic B.
Brückner, Martina
Hadjihannas, Michel V.
Behrens, Jürgen
author_facet Bernkopf, Dominic B.
Brückner, Martina
Hadjihannas, Michel V.
Behrens, Jürgen
author_sort Bernkopf, Dominic B.
collection PubMed
description The paralogous scaffold proteins axin and conductin/axin2 are key factors in the negative regulation of the Wnt pathway transcription factor β-catenin, thereby representing interesting targets for signaling regulation. Polymerization of axin proteins is essential for their activity in suppressing Wnt/β-catenin signaling. Notably, conductin shows less polymerization and lower activity than axin. By domain swapping between axin and conductin we here identify an aggregation site in the conductin RGS domain which prevents conductin polymerization. Induction of conductin polymerization by point mutations of this aggregon results in enhanced inhibition of Wnt/β-catenin signaling. Importantly, we identify a short peptide which induces conductin polymerization via masking the aggregon, thereby enhancing β-catenin degradation, inhibiting β-catenin-dependent transcription and repressing growth of colorectal cancer cells. Our study reveals a mechanism for regulating signaling pathways via the polymerization status of scaffold proteins and suggests a strategy for targeted colorectal cancer therapy.
format Online
Article
Text
id pubmed-6751202
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67512022019-09-20 An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy Bernkopf, Dominic B. Brückner, Martina Hadjihannas, Michel V. Behrens, Jürgen Nat Commun Article The paralogous scaffold proteins axin and conductin/axin2 are key factors in the negative regulation of the Wnt pathway transcription factor β-catenin, thereby representing interesting targets for signaling regulation. Polymerization of axin proteins is essential for their activity in suppressing Wnt/β-catenin signaling. Notably, conductin shows less polymerization and lower activity than axin. By domain swapping between axin and conductin we here identify an aggregation site in the conductin RGS domain which prevents conductin polymerization. Induction of conductin polymerization by point mutations of this aggregon results in enhanced inhibition of Wnt/β-catenin signaling. Importantly, we identify a short peptide which induces conductin polymerization via masking the aggregon, thereby enhancing β-catenin degradation, inhibiting β-catenin-dependent transcription and repressing growth of colorectal cancer cells. Our study reveals a mechanism for regulating signaling pathways via the polymerization status of scaffold proteins and suggests a strategy for targeted colorectal cancer therapy. Nature Publishing Group UK 2019-09-18 /pmc/articles/PMC6751202/ /pubmed/31534175 http://dx.doi.org/10.1038/s41467-019-12203-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Bernkopf, Dominic B.
Brückner, Martina
Hadjihannas, Michel V.
Behrens, Jürgen
An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
title An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
title_full An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
title_fullStr An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
title_full_unstemmed An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
title_short An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy
title_sort aggregon in conductin/axin2 regulates wnt/β-catenin signaling and holds potential for cancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751202/
https://www.ncbi.nlm.nih.gov/pubmed/31534175
http://dx.doi.org/10.1038/s41467-019-12203-8
work_keys_str_mv AT bernkopfdominicb anaggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy
AT brucknermartina anaggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy
AT hadjihannasmichelv anaggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy
AT behrensjurgen anaggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy
AT bernkopfdominicb aggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy
AT brucknermartina aggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy
AT hadjihannasmichelv aggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy
AT behrensjurgen aggregoninconductinaxin2regulateswntbcateninsignalingandholdspotentialforcancertherapy